1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
684BC3B349E769FB585257AA0006E57C0
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/monitoring-relationships-with-acos-state-health-exchanges-medicaid-offices
18
19
203.91.157.213
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Quality, Compliance and Regulatory Government Affairs and Public Policy

Managing Healthcare Reform: Government Affairs, Public Policy and Managing State-Level Relationships with ACOs, Medicaid, and Health Exchanges

ID: 5226


Features:

21 Info Graphics

9 Data Graphics

80+ Metrics

9 Narratives


Pages/Slides: 37


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Managing Healthcare Reform: Government Affairs, Public Policy and Managing State-Level Relationships with ACOs, Medicaid, and Health Exchanges"


STUDY OVERVIEW

Government Affairs and Public Policy are the key functions that interact with the government healthcare sector. As healthcare reform unfolds, it has become increasingly important to effectively monitor and manage relationships with state-level government agencies. Likewise, the emerging roles of Accountable Care Organizations (ACOs), State Health Exchanges and Medicaid mandate that organizations establish clear lines of responsibility for monitoring and managing these entities.

Best Practices, LLC conducted this research to help leaders across key functions evaluate their approach to monitoring and engaging new entities such as ACOs, State Health Exchanges and Medicaid offices. The study identifies how companies are better positioning themselves to manage the Washington ecosystem and coordinating responsibilities.

The study includes three segments: a Large Pharma Segment, a Mid-Cap Pharma Segment, and an Emerging Pharma segment.

KEY TOPICS

  • Executive Overview
  • Managing State-Level Relationships
  • Future Trends & Lessons Learned

SAMPLE KEY METRICS
  • Does Organization have Engagement Strategy for ACOs
  • Does Organization have Engagement Strategy for State Medicaid Offices
  • Does Organization have Engagement Strategy for State Health Exchanges
  • Role of Key Functions Regarding State-Level Relationship Management
  • Location of Function that Handles State-Level Relationships

SAMPLE KEY FINDING
  • A majority of study participants have an engagement strategy for state-level relationships related to state health exchanges, ACOs and state Medicaid offices. The Large Pharma Segment is particularly focused on state Medicaid offices (100% have engagement strategies) and state health exchanges (75%), but a majority also have engagement strategies for ACOs (62%). All of these entities will play a critical role in how consumers access therapies
METHODOLOGY

Best Practices, LLC engaged 23 experienced executives, mainly in Government Affairs, Public Policy and Managed Markets, from 23 different pharmaceutical companies. In addition, deep-dive interviews were conducted with six participating companies to gather additional insights.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Amylin; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Cubist; Daiichi-Sankyo; GE Healthcare; Genentech; GlaxoSmithKline; IDEA Pharma; Integrated Diagnostics; Merck; Millenium; Novo Nordisk; ProStraken; Purdue; Sagent; Sanofi; Shionogi; Shire; Smith & Nephew


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.